DermTech Melanoma Test: Summary

DermTech Melanoma Test

Healthcare, Medical Diagnostics, Dermatology, Genomics

The DermTech Melanoma Test offers a highly reliable method to rule out melanoma, providing clinicians with confidence in their assessments and improving patient outcomes.

The DermTech Melanoma Test is a non-invasive genomic test that utilizes DermTech Smart Stickers to assess melanocytic lesions. It detects genomic markers associated with melanoma, providing a reliable method to distinguish between benign and higher-risk lesions.

99% negative predictive value (NPV); Non-invasive testing using Smart Stickers; Objective and actionable results; CLIA certified and JCO accredited laboratory

The DermTech Melanoma Test is most valuable in scenarios where clinicians need to assess ambiguous pigmented lesions and rule out melanoma without invasive procedures.

High accuracy with a 99% negative predictive value; Non-invasive testing method that is easier for patients; Objective results that reduce subjectivity in diagnosis

The test's high sensitivity and specificity, along with its non-invasive approach, make it a strong tool for clinicians in managing equivocal pigmented lesions.

DermTech positions itself as a leader in precision genomics for dermatology, focusing on innovative solutions for melanoma detection.

The primary target users are dermatologists and healthcare providers who manage skin lesions, as well as patients concerned about melanoma.

Let's Get Started

• Melanoma Test

• Genomic Testing

• Non-invasive

• Precision Medicine

Rule Out Melanoma with Precision Genomics

Professional, informative, reassuring

The DermTech Melanoma Test stands out due to its non-invasive nature and the use of genomic markers to provide objective results, which is a significant advancement over traditional visual assessments.

DermTech is identified as a cutting-edge company in the dermatology field, emphasizing safety, quality, and advanced genomic testing.

1996-01-01

• John Dobak